Kiniksa Pharmaceuticals International
KNSA | NASDAQ
$78.80
+$0.67 (+0.86%)
Sep 22, 2026, 10:49 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 165.6M | 183.58M | 107.95M | 122.72M | 122.47M | 114.04M |
Short-Term Investments | 248.48M | 60.05M | 98.42M | 67.89M | 59.73M | 209.44M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 11.31M | 10.32M | 827K | 5.82M | 8.72M | 5.59M |
Receivables | 15.59M | 41.72M | 21.27M | 20.32M | 3.99M | n/a |
Inventory | 54.9M | 26.36M | 31.12M | 21.6M | 3.68M | n/a |
Other Current Assets | 42.61M | 20.08M | 17.54M | 10.54M | n/a | 210K |
Total Current Assets | 527.18M | 331.8M | 276.3M | 243.06M | 196.45M | 333.25M |
Property-Plant & Equipment | 11.75M | 11.04M | 12.67M | 7.04M | 8.38M | 10.62M |
Goodwill & Intangibles | 15.25M | 16.25M | 17.25M | 18.25M | 19.25M | n/a |
Total Long-Term Assets | 236.46M | 248.75M | 250.03M | 216.61M | 36.35M | 16.22M |
Total Assets | 763.63M | 580.55M | 526.32M | 459.67M | 232.8M | 349.46M |
Account Payables | 2.03M | 2.04M | 8.25M | 7.9M | 1.87M | 503K |
Deferred Revenue | 31.81M | n/a | 307K | n/a | n/a | n/a |
Short-Term Debt | 2.99M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 102.36M | 33.12M | 36.91M | 16.97M | 1.54M | 7.74M |
Total Current Liabilities | 139.18M | 100.62M | 63.67M | 47.07M | 44.82M | 31.85M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 18.52M | 1.82M | 1.86M | 1.84M | 270K | 805K |
Total Long-Term Liabilities | 56.84M | 41.5M | 23.82M | 16.46M | 2.94M | 5.68M |
Total Liabilities | 196.03M | 142.12M | 87.48M | 63.52M | 47.76M | 37.53M |
Total Debt | 9.5M | 9.86M | 12.26M | 5.92M | 6.05M | 6.99M |
Book Value | 567.61M | 438.44M | 438.84M | 396.15M | 185.04M | 311.94M |
Book Value Per Share | 7.19 | 6.14 | 6.10 | 5.63 | 2.70 | 5.04 |
Common Stock | 21K | 20K | 20K | 19K | 18K | 18K |
Retained Earnings | -462.14M | -521.14M | -477.95M | -492.03M | -675.4M | -517.47M |
Comprehensive Income | -25K | -163K | 6K | 44K | -66K | -34K |
Shareholders Equity | 567.61M | 438.44M | 438.84M | 396.15M | 185.04M | 311.94M |
Total Investments | 248.48M | 60.05M | 98.42M | 67.89M | 59.73M | 209.44M |
Add to Watchlist
Select watchlists to add or remove KNSA